Sex-bias in CD8
Journal
Clinical & translational immunology
ISSN: 2050-0068
Titre abrégé: Clin Transl Immunology
Pays: Australia
ID NLM: 101638268
Informations de publication
Date de publication:
2022
2022
Historique:
received:
08
08
2022
revised:
11
08
2022
accepted:
11
08
2022
entrez:
2
9
2022
pubmed:
3
9
2022
medline:
3
9
2022
Statut:
epublish
Résumé
This commentary article highlights two recently published studies, which for the first time revealed the immunological underpinnings of sex-bias in cancer incidence and mortality. These studies showed that the androgen receptor restrains anti-tumour immunity in males by repressing cytotoxic genes in CD8
Identifiants
pubmed: 36051310
doi: 10.1002/cti2.1414
pii: CTI21414
pmc: PMC9418121
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e1414Informations de copyright
© 2022 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Nature. 2020 Mar;579(7800):581-585
pubmed: 32103173
Nat Rev Immunol. 2020 Feb;20(2):128-136
pubmed: 31591533
Sci Signal. 2018 Apr 17;11(526):
pubmed: 29666308
Annu Rev Immunol. 2022 Apr 26;40:75-94
pubmed: 34985929
Immunity. 2022 Jul 12;55(7):1268-1283.e9
pubmed: 35700739
Nature. 2022 Jun;606(7915):797-803
pubmed: 35705814
Nat Rev Immunol. 2016 Oct;16(10):626-38
pubmed: 27546235
Sci Immunol. 2022 Jul;7(73):eabq2630
pubmed: 35420889
Nat Rev Immunol. 2010 Aug;10(8):594-604
pubmed: 20651746
Nat Rev Cancer. 2021 Jun;21(6):393-407
pubmed: 33879867
Nature. 2020 Dec;588(7837):315-320
pubmed: 32846427
Nat Rev Immunol. 2022 Apr;22(4):209-223
pubmed: 34253904
Nature. 2022 Jun;606(7915):791-796
pubmed: 35322234